Company: PFSA
Filing Date: 2025-10-29
Form Type: 424B3
Source: 0001213900-25-103174
Chunk: 344

Company: Profusa, Inc.
Filing Date: 2025-10-29
Form: 424B3
Chunk 344
---
                                                           |     |                  |    318 |   |     |   |    162 |   |
| Legal and accounting costs                                                      |     |                  |    649 |   |     |   |    592 |   |
| Other expenses(1)                                                               |     |                  |     66 |   |     |   |     41 |   |
| Total segment expenses                                                          |     |                  |  2,427 |   |     |   |  2,340 |   |
| Loss from operations                                                            |     |                  | (2,427 | ) |     |   | (2,315 | ) |
| Other income (expense)                                                          |     |                  |        |   |     |   |        |   |
| Loss on change in the fair value of related party Tasly convertible debt        |     |                  |   (118 | ) |     |   |    (11 | ) |
| Interest expense                                                                |     |                  | (2,519 | ) |     |   | (2,161 | ) |
| Other income                                                                    |     |                  |      — |   |     |   |      6 |   |
| Total other expense, net                                                        |     |                  | (2,637 | ) |     |   | (2,166 | ) |
| Net loss and comprehensive loss                                                 |     | $                | (5,064 | ) |     | $ | (4,481 | ) |

| (1) | Other expenses includes small balances of research materials and supplies along with insurance costs. |

The Company has no significant
long-lived assets recognized on the Consolidated Balance Sheets.

Note 14 — Subsequent Events

The Company has evaluated its
subsequent events from June 30, 2025, through the date these condensed consolidated financial statements were issued and has determined
that there are no subsequent events requiring disclosure in these condensed consolidated financial statements other than the items
noted below.

On November 7, 2022, the
Company entered into the Merger Agreement with NorthView, and on July 11, 2025, the Business Combination closed. In accordance with
the terms and subject to the conditions of the Merger Agreement, at Closing, each share of issued and outstanding Profusa Common Stock
was converted into a number of shares of New Profusa Common Stock, based on the Exchange Ratio that reflects an equity valuation of Profusa
of $155,000,000